Literature DB >> 16806064

HB-EGF: increase in the ischemic rat retina and inhibition of osmotic glial cell swelling.

Malte Weuste1, Antje Wurm, Ianors Iandiev, Peter Wiedemann, Andreas Reichenbach, Andreas Bringmann.   

Abstract

We determined whether the expression of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in the sensory rat retina alters during ischemia-reperfusion, and whether HB-EGF affects the osmotic swelling which is a characteristic feature of Müller glial cells after ischemia. Transient retinal ischemia was induced by elevation of the intraocular pressure for 1 h. Western blots revealed an upregulation of HB-EGF in the retina at 1, 3, and 7 days after reperfusion. HB-EGF inhibited the swelling of glial cells in retinal slices, via stimulation of the synaptic release of glutamate and subsequent activation of glial metabotropic glutamate receptors which resulted in an autocrine release of purinergic receptor agonists. Finally, activation of A1 receptors resulted in opening of glial K(+) and Cl(-) channels. It is suggested that the increased expression of HB-EGF and the inhibition of glial cell swelling may be parts of a protective role of HB-EGF in the ischemic retina.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806064     DOI: 10.1016/j.bbrc.2006.06.077

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury.

Authors:  Chun-Liang Chen; Jixin Yang; Iyore O A James; Hong-Yi Zhang; Gail E Besner
Journal:  Surgery       Date:  2014-02-06       Impact factor: 3.982

2.  Tight junction proteins at the blood-brain barrier: far more than claudin-5.

Authors:  Philipp Berndt; Lars Winkler; Jimmi Cording; Olga Breitkreuz-Korff; André Rex; Sophie Dithmer; Valentina Rausch; Rosel Blasig; Matthias Richter; Anje Sporbert; Hartwig Wolburg; Ingolf E Blasig; Reiner F Haseloff
Journal:  Cell Mol Life Sci       Date:  2019-02-07       Impact factor: 9.261

3.  Tight junctions in the blood-brain barrier promote edema formation and infarct size in stroke - Ambivalent effects of sealing proteins.

Authors:  Lars Winkler; Rosel Blasig; Olga Breitkreuz-Korff; Philipp Berndt; Sophie Dithmer; Hans C Helms; Dmytro Puchkov; Kavi Devraj; Mehmet Kaya; Zhihai Qin; Stefan Liebner; Hartwig Wolburg; Anuska V Andjelkovic; Andre Rex; Ingolf E Blasig; Reiner F Haseloff
Journal:  J Cereb Blood Flow Metab       Date:  2020-02-13       Impact factor: 6.200

Review 4.  Purinergic signaling in the retina: From development to disease.

Authors:  Ana Lucia Marques Ventura; Alexandre Dos Santos-Rodrigues; Claire H Mitchell; Maria Paula Faillace
Journal:  Brain Res Bull       Date:  2018-11-17       Impact factor: 4.077

Review 5.  Purinergic neuron-glia interactions in sensory systems.

Authors:  Christian Lohr; Antje Grosche; Andreas Reichenbach; Daniela Hirnet
Journal:  Pflugers Arch       Date:  2014-04-06       Impact factor: 3.657

6.  Gene expression analysis of ischaemia and reperfusion in human microsurgical free muscle tissue transfer.

Authors:  Adrian Dragu; Stefan Schnürer; Cordula Surmann-Schmitt; Klaus von der Mark; Michael Stürzl; Frank Unglaub; Maya B Wolf; Mareike Leffler; Justus P Beier; Ulrich Kneser; Raymund E Horch
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

7.  PDGF Receptor Alpha Signaling Is Key for Müller Cell Homeostasis Functions.

Authors:  Nundehui Díaz-Lezama; Anne Wolf; Susanne Koch; Anna M Pfaller; Josef Biber; Xavier Guillonneau; Thomas Langmann; Antje Grosche
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

8.  Osmotic Induction of Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells.

Authors:  Moritz Veltmann; Margrit Hollborn; Andreas Reichenbach; Peter Wiedemann; Leon Kohen; Andreas Bringmann
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.